The Journal of Clinical Microbiology has a great tradition of publishing mini-reviews on topics that are important to the clinical microbiology community. Minireviews provide “up to the minute” updates on topics pertinent to clinical microbiologists and serve as fabulous training tools for medical professionals, trainees, and researchers across all disciplines. Dr. Humphries and Dr. Ledeboer discuss what makes a great mini-review, and their favorite mini-reviews published in JCM.

Watch this episode: https://youtu.be/sXOrfTkoDGM

This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM).

Editors in conversation is supported by the American Society for Microbiology, which publishes JCM. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at https://asm.org/joinasm.

Visit https://journals.asm.org/journal/jcm to read articles and/or submit a manuscript.

Subscribe to the podcast at https://asm.org/eic

Antimicrobial resistance is one of the largest threats to global public health, compromising all other advances in modern medicine. At the forefront of detecting AMR is the clinical laboratory.

However, walk into any clinical microbiology laboratory today and you will find this important task being accomplished using techniques that barely evolved from the methods proposed by Alexander Fleming, nearly 100 years ago.

Bacteria are exposed to antimicrobials, in an in vitro culture system, and growth inhibition is measured after overnight incubation. In the time of laboratory automation, molecular testing and artificial intelligence – are we ready for an antimicrobial susceptibility testing revolution? What are the technologies that might get us there?

• Dr. Daniel Rhodes
• Dr. Jacob Rattin

https://journals.asm.org/doi/10.1128/jcm.00674-25

This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). JCM is available at jcm.asm.org.

Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.

Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.

Measles is becoming an important public health problem and it is important to recognize and understand the origins of this problem and how it can affect the population of our country. At the same time, it is critical to have updated and scientifically accurate information on the clinical presentations, risk factors and countermeasures. Today, we will discuss this topic with experts in field.

Watch this episode: https://youtu.be/oQDaa8J9v5w

Topics:

• Define measles as an important public health threat
• Explain the origin of the epidemic
• Accurate information on countermeasures and strategies to tackle this outbreak.

Guests:

- Hana Mohammed El Sahly, M.D. Professor, Kyle and Josephine Morrow Chair, Department of Medicine, Molecular Virology and Microbiology; Vaccine and Treatment Evaluation Unit (VTEU)
Baylor College of Medicine Houston, TX US.

- Natasha B. Halasa M.D., M.P.H. Craig Weaver Professor of Pediatrics, Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University, Nashville Tennessee

This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at https://asm.org/aac.

If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up.

Visit https://asm.org/aac to browse issues and/or submit a manuscript.

Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.

Subscribe to the podcast at https://asm.org/eic